Spots Global Cancer Trial Database for resectable pancreatic cancer
Every month we try and update this database with for resectable pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer | NCT06203821 | Pancreatic Canc... | NP137 | 18 Years - | University of Rochester | |
| Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer | NCT05788744 | Resectable Panc... | ctDNA | - | Copenhagen University Hospital at Herlev | |
| Intraoperative Radiation Therapy for Resectable Pancreatic Cancer | NCT05181488 | Resectable Panc... | intraoperative ... | 20 Years - | Gangnam Severance Hospital | |
| Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study | NCT02345460 | Pancreatic Aden... Poorly Differen... Resectable Panc... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Undifferentiate... | Irinotecan Hydr... Oxaliplatin Leucovorin Calc... Fluorouracil Laboratory Biom... | 18 Years - 75 Years | Case Comprehensive Cancer Center | |
| Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer | NCT01298011 | Resectable Panc... | Gemcitabine and... | 18 Years - | Pancreatic Cancer Research Team | |
| Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer | NCT00243854 | Pancreatic Canc... | Tarceva | 18 Years - | Indiana University | |
| A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer | NCT01694589 | Resectable Panc... | LDE-225 | 18 Years - | Rutgers, The State University of New Jersey | |
| Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer | NCT01494155 | Pancreatic Canc... | Capecitabine Hydroxychloroqu... Proton or Photo... | 18 Years - | Massachusetts General Hospital | |
| Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer | NCT01494155 | Pancreatic Canc... | Capecitabine Hydroxychloroqu... Proton or Photo... | 18 Years - | Massachusetts General Hospital | |
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | NCT03822936 | Cancer of Pancr... Pancreas Adenoc... Resectable Panc... | Preoperative ch... Preoperative ra... | 18 Years - 75 Years | CNAO National Center of Oncological Hadrontherapy | |
| Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study | NCT04737551 | Resectable Panc... Adjuvant Chemor... Surgery | Follow-up only Adjuvant chemot... Adjuvant chemor... Adjuvant chemor... | 18 Years - 90 Years | Shanghai Zhongshan Hospital | |
| Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer | NCT05788744 | Resectable Panc... | ctDNA | - | Copenhagen University Hospital at Herlev | |
| Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | NCT05209074 | Pancreatic Duct... Resectable Panc... | Ivosidenib mFOLFIRINOX | 18 Years - 80 Years | Case Comprehensive Cancer Center | |
| Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients | NCT03392571 | Resectable Panc... | NGC-Triple regi... | 18 Years - 75 Years | Pancreatic Cancer Research Team | |
| A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma | NCT05066802 | Resectable Panc... | neoadjuvant mod... | 19 Years - | Yonsei University | |
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | NCT03822936 | Cancer of Pancr... Pancreas Adenoc... Resectable Panc... | Preoperative ch... Preoperative ra... | 18 Years - 75 Years | CNAO National Center of Oncological Hadrontherapy | |
| A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer | NCT01694589 | Resectable Panc... | LDE-225 | 18 Years - | Rutgers, The State University of New Jersey | |
| ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing | NCT05380557 | Pancreatic Aden... Pancreatic Canc... Resectable Panc... | Germline geneti... | 18 Years - | Invitae Corporation | |
| Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | NCT00766636 | Pancreatic Canc... | Gemcitabine Radiation Thera... Erlotinib Surgery | 18 Years - | M.D. Anderson Cancer Center | |
| Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer | NCT03718650 | Pancreatic Canc... Resectable Panc... | Pimonidazole Surgical Resect... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer | NCT02775695 | Resectable Panc... | Doxycycline | 18 Years - | Medical College of Wisconsin | |
| Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer | NCT02775695 | Resectable Panc... | Doxycycline | 18 Years - | Medical College of Wisconsin | |
| Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer | NCT03435536 | Resectable Panc... | Blood samples | 18 Years - | University Hospital, Toulouse | |
| A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | NCT05546411 | Pancreatic Canc... Resectable Panc... Borderline Rese... Pancreatic Aden... | mFOLFIRINOX 5-Fluorouracil ... Oxaliplatin Irinotecan Leucovorin NIS793 Chemoradiation Surgery | 18 Years - | Dana-Farber Cancer Institute | |
| Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | NCT00766636 | Pancreatic Canc... | Gemcitabine Radiation Thera... Erlotinib Surgery | 18 Years - | M.D. Anderson Cancer Center | |
| NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) | NCT05529940 | Resectable Panc... Neoadjuvant Che... Effects of Chem... | Folfirinox | 19 Years - 80 Years | Seoul National University Hospital | |
| EUS vs. MDCT in Pancreatic Malignancy | NCT02115022 | Resectable Panc... | 18 Years - | Clinical Hospital Colentina | ||
| Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer | NCT05679050 | Resectable Panc... | AG Followed by ... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) | NCT05529940 | Resectable Panc... Neoadjuvant Che... Effects of Chem... | Folfirinox | 19 Years - 80 Years | Seoul National University Hospital | |
| Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer | NCT06168552 | Resectable Panc... | Injection of fl... | 18 Years - | Zhejiang University | |
| A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer | NCT06363084 | Resectable Panc... | Nimotuzumab | 18 Years - | Ruijin Hospital | |
| EUS vs. MDCT in Pancreatic Malignancy | NCT02115022 | Resectable Panc... | 18 Years - | Clinical Hospital Colentina | ||
| Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer | NCT03435536 | Resectable Panc... | Blood samples | 18 Years - | University Hospital, Toulouse | |
| Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer | NCT02767752 | Pancreatic Canc... | T-ChOS Gemcitabine Placebo Capecitabine | 18 Years - | Herlev Hospital | |
| A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer | NCT03528785 | Pancreatic Aden... | Irinotecan Lipo... | 18 Years - | Centro Ricerche Cliniche di Verona | |
| Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer | NCT03492671 | Pancreas Adenoc... Resectable Panc... | Gemcitabine 100... nab-paclitaxel Stereotactic Bo... | 18 Years - | Loma Linda University | |
| A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | NCT05546411 | Pancreatic Canc... Resectable Panc... Borderline Rese... Pancreatic Aden... | mFOLFIRINOX 5-Fluorouracil ... Oxaliplatin Irinotecan Leucovorin NIS793 Chemoradiation Surgery | 18 Years - | Dana-Farber Cancer Institute | |
| Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) | NCT01964430 | Pancreatic Neop... Digestive Syste... Neoplasms by Si... Neoplasms Endocrine Gland... Pancreatic Dise... Digestive Syste... Endocrine Syste... Gemcitabine Antimetabolites... | nab-Paclitaxel Gemcitabine | 18 Years - | Celgene | |
| GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma | NCT04472910 | Resectable Panc... | Modified Folfor... | 18 Years - | University Health Network, Toronto | |
| Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy | NCT04810910 | Resectable Panc... | iNeo-Vac-P01 GM-CSF | 18 Years - 70 Years | Zhejiang Provincial People's Hospital | |
| Pre-operative Treatment for Patients With Untreated Pancreatic Cancer | NCT03138720 | Resectable Panc... Unresectable Pa... Pancreatic Aden... Neoadjuvant Pan... | Paclitaxel Prot... | 18 Years - | HonorHealth Research Institute | |
| Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study | NCT02782182 | Pancreatic Duct... | FOLFIRINOX (oxa... | 18 Years - | University of Chicago | |
| A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer | NCT03528785 | Pancreatic Aden... | Irinotecan Lipo... | 18 Years - | Centro Ricerche Cliniche di Verona | |
| Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer | NCT03492671 | Pancreas Adenoc... Resectable Panc... | Gemcitabine 100... nab-paclitaxel Stereotactic Bo... | 18 Years - | Loma Linda University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
